StockData
Atara Biotherapeutics, Inc. logo

Atara Biotherapeutics, Inc. (ATRA) stock

ATRANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 3/30
$6.77+0.27 (+4.15%)

Close on Nov 18, 2026Market cap $67.96MP/E –Yield –

Atara Biotherapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Atara Biotherapeutics's price to book ratio was 0.7× on Apr 30, 2024, against 2.6× a year earlier. Over the last 5 years it ranged from 0.7× to 20.1×, with a median of 2.7×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Apr 30, 20240.7×−16.8
2023Oct 31, 202317.5×+15.8
2022Dec 30, 20221.7×−2.8
2021Dec 31, 20214.5×+0.2
2020Dec 31, 20204.3×+1.5
2019Dec 31, 20192.8×−1.1
2018Dec 31, 20183.9×+3.9
2017Dec 29, 20170.0×−1.5
2016Dec 30, 20161.5×−0.7
2015Dec 31, 20152.2×–

More Atara Biotherapeutics figures

See a number that looks wrong?